Neuronetrix completes significant clinical study milestone using Cognision system for early diagnosis of Alzheimer’s disease
The multi-year study was designed to evaluate the system’s ability to discriminate early stage Alzheimer’s patients from age-matched healthy controls. The trial enrolled over 200 subjects at 7